Clinical trials
Withdrawn Fallopian Tube Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| Gynecologic Oncology Group | 2 |
| M.D. Anderson Cancer Center | 2 |
| Roswell Park Cancer Institute | 2 |
| Fox Chase Cancer Center | 1 |
| Genzyme, a Sanofi Company | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 13 |
| Ovarian Neoplasms | 11 |
| Carcinoma, Ovarian Epithelial | 2 |
| Uterine Cervical Neoplasms | 2 |
| Endometrial Neoplasms | 1 |
| Hereditary Breast and Ovarian Cancer Syndrome | 1 |
| Neoplasm Metastasis | 1 |
| Pleural Effusion, Malignant | 1 |
| Uterine Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.